The first trial concerning Johnson and Johnson’s faulty DePuy Pinnacle MDL hip replacement devices began earlier this month in the U.S. District Court, Northern District of Texas. This bellwether trial centers on the case of a 58-year-old Montana woman who has experienced a number of complications directly stemming from the DePuy hip replacement system. This lawsuit intends to prove that the plaintiff was exposed to metal debris during the insertion of the DePuy product, and as a result of this exposure, the plaintiff has suffered a variety of other serious complications.
In this third week of the trial, a vice president from DePuy Orthopedics will be testifying about the safety precautions that DePuy claims to have taken in regards to its Pinnacle product. An attorney for the company has previously stated that the hip replacement products work “99.9% of the time.”
At present, there have been over 6,000 federal MDL lawsuits filed against J&J’s DePuy Orthopedics division because of its Pinnacle hip product; the plaintiffs who filed these suits would most certainly disagree with the claims that this product works 99.9% of the time. Reasons for filing suit vary from claimant to claimant, but side effects and complications that these plaintiffs have experienced include (but are not limited to) metal poisoning, kidney and bladder cancers, and dead tissue or bone loss around the joint.
Over 93,000 individuals worldwide have had DePuy’s artificial hip installed during the 8 year period that it was on the market. It was recalled in 2010 after the FDA received hundreds of complaints from patients who were suffering after the devices failed. Since then, thousands of other complaints have been accumulated from patients who also experienced device failure, had to go through additional surgeries due to premature device failure, or suffered complications because of the device.
Written by Shayna Keyles